“Researchers at ETH Zurich have developed a lithium-ion battery made entirely of solid material: it contains neither liquids nor gels. The battery cannot ignite, even at very high temperatures, giving it a safety advantage over conventional batteries. In addition, they allow new forms of battery design.”
Interesting read; like the plug by Rajeev Alur about how the insights from the ExCAPE project has helped advance making QC programmable. Like Alur, I too see many synergies across multiple areas of science & tech. For example, the work on singularity is being advance by the work performed around anti-aging, cancer research, etc. and vice versa. Truly one of my biggest enjoyments of research and innovation is taking a accept or vision, and guessing where else can the concept be leveraged or even advancing other industries.
NSF’s mission is to advance the progress of science, a mission accomplished by funding proposals for research and education made by scientists, engineers, and educators from across the country.
Where there is water, there is life. This is a statement that has been reaffirmed over and over again. Whether it is in the acidic waters surrounding volcanoes or in the dark and frozen wastes of the icy Antarctic, wherever we find liquid water, we find life. That’s what makes one of the most recent finds by NASA’s Curiosity rover so amazing—Evidence of liquid water on Mars. And even more recently (this month, in fact), NASA announced that it had confirmed evidence of water flowing on Mars.
Granted, this “flowing water” is really more of a trickle (damp soil, if you will), but the find is still exciting for a number of reasons.
To begin, as early as 2002, we confirmed that there was ice on the Red Planet. Soon after, we found that Mars has more than just a little ice. It has glaciers. Ultimately, this frozen ice contains enough water to cover the entire planet in a meter of water.
Posted in government, robotics/AI, science, transhumanism | 1 Comment on I stopped by the NYC office today and chatted with veteran science writer John Horgan live on their Facebook page about transhumanism and my campaign
It reminds of the medieval knight armor.
Power Armor. A powered exoskeleton with a tough outer shell, coupled with twice the mobility of a normal soldier and the strength of an elephant.
For decades, media has emulated what scientists have been struggling to create for millennia. Armor strong enough to both protect the wearer, and strengthen them through mechanical support.
In recent years, researchers have nearly achieved this kind of technology, with body armor reaching durability tougher than steel, and hobbyists making exoskeletons which can lift hundreds of pounds.
Posted in aging, bioengineering, biotech/medical, DNA, health, life extension, neuroscience, posthumanism, science, transhumanism | Leave a Comment on Bioquark Inc. and RegenerAge SAPI de CV to Collaborate on Clinical Regenerative Healthcare
Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.
“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”
As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.
With the emergence of such trends including: personalization of medicine on an “n-of-1” basis, adaptive clinical design, globalization of health care training, compassionate use legislative initiatives for experimental therapies, wider acceptance of complementary medical technologies, and the growth of international medical travel, patients and clinicians are more than ever before, exploring the ability to access the therapies of tomorrow, today.
The estimate of the current market size for procedural medical travel, defined by medical travelers who travel across international borders for the purpose of receiving medical care, is in the range of US $40–55 billion.
Additionally, major clinical trial gaps currently exist across all therapeutic segments that are responsible for human suffering and death. Cancer is one prime example. As a leading cause of morbidity and mortality worldwide for many decades, today there are approximately 14 million new cases diagnosed each year, with over 8 million cancer related deaths annually. It is estimated that less than 5% of these patients, take the initiative to participate in any available clinical studies.
“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Dr. Joel Osorio, Chief of Clinical Development RegenerAge SAPI de CV. “The ability to merge cellular and biologic approaches represents the next step in achieving comprehensive regeneration and disease reversion events in a range of chronic diseases responsible for human suffering and death.”
About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.
About RegenerAge SAPI de CV
RegenerAge SAPI de CV is a novel clinical company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.
We spend our lives surrounded by hi-tech materials and chemicals that make our batteries, solar cells and mobile phones work. But developing new technologies requires time-consuming, expensive and even dangerous experiments.
Luckily we now have a secret weapon that allows us to save time, money and risk by avoiding some of these experiments: computers.
Thanks to Moore’s law and a number of developments in physics, chemistry, computer science and mathematics over the past 50 years (leading to Nobel Prizes in Chemistry in 1998 and 2013) we can now carry out many experiments entirely on computers using modelling.
The methane seems to bloom in the Martian summers when the atmosphere is viewed with spectrography lenses on powerful telescopes I read once. Which always made me wonder if there’s algae of some form in the subsoil.
Scientists are getting closer to solving one of the biggest Martian mysteries.
A new story with lots of transhumanism in it:
Zoltan Istvan is in the running for President of the United States. You may not have heard of him, but if elected, he hopes to put an end to death. All of it. (Yes, seriously).
There are people right now walking around with artificial hearts – something that many people believed would not happen for another decade (or even longer). There are quadriplegics no longer bound to a wheelchair, but walk with exoskeleton technology. There are hundreds of thousands of people with brain implants that help them with various ailments. In short, recent technological breakthroughs like these open up the possibility for humans to enhance themselves and their health—and perhaps to even become immortal (someday).
As you can imagine, such radical developments demand strong, intelligent and science-focused political leadership. That is why Zoltan Istvan, of the Transhumanist Party, says that he is running for U.S. President this year, as the #ScienceCandidate.
He thinks that, by encouraging America to embrace science and technology, we could transform our lives and the planet by overcoming poverty, aging, and even death…and all in the coming generation.
